Patient info Open main menu

L04AB02 infliximab

ATC group of level 5 – chemical substance · in plain English: medicines suppressing the immune system, e.g. after a transplant or for autoimmune diseases

This site has the patient leaflet or the SPC of 7 medicines in this group.

Active substance: Infliximab – all medicines with this substance, also in combinations.

Place in the ATC classification

  1. L Antineoplastic and immunomodulating agents 1,791 medicines
    1. L04 Immunosuppressants 545 medicines
      1. L04A Immunosuppressants 543 medicines
        1. L04AB Tumor necrosis factor alpha (TNF-alpha) inhibitors 75 medicines
          1. L04AB02 infliximab 7 medicines

Medicines

MedicineLegal category
Flixabi SPC Prescription only (POM)
Flixabi 100 mg powder for concentrate for solution for infusion SPC Prescription only (POM)
Inflectra 100 mg powder for concentrate for solution for infusion SPC no longer supplied –
Remicade 100 mg powder for concentrate for solution for infusion SPC Prescription only (POM)
Remsima 100 mg powder for concentrate for solution for infusion SPC –
Remsima 120 mg solution for injection in Pre-filled pen SPC Prescription only (POM)
Zessly 100 mg powder for concentrate for solution for infusion SPC Prescription only (POM)

Other groups of the same level

Other names of the ATC group

Sources

  • Patient leaflets and SPCs: the MHRA product information (products.mhra.gov.uk) and the European Medicines Agency (EMA)
  • Active substances, ATC codes and legal categories: the NHS Dictionary of Medicines and Devices (dm+d), NHS Business Services Authority
  • World Health Organization (WHO): ATC/DDD classification, group L04AB02

Contains public sector information licensed under the Open Government Licence v3.0.

Ask your doctor or pharmacist which medicine is right for you.